David H. Gültekin

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors

A. Craig Lockhart, Mace L. Rothenberg, Jakob Dupont et al. · Journal of Clinical Oncology · 2009 · 235 citations · Full text

Medicine, Oncology, Pharmacology +17

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

William R. Jarnagin, Lawrence H. Schwartz, David H. Gültekin et al. · Annals of Oncology · 2009 · 190 citations · Full text

Medicine, Oncology, Radiology +16

Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer

Marc J. Gollub, David H. Gültekin, James L. Fuqua et al. · European Radiology · 2011 · 129 citations

Medicine, Oncology, Radiology +17

Multiparametric Prostate MR Imaging with T2-weighted, Diffusion-weighted, and Dynamic Contrast-enhanced Sequences: Are All Pulse Sequences Necessary to Detect Locally Recurrent Prostate Cancer after Radiation Therapy?

Olivio F. Donati, Sung Il Jung, Hebert Alberto Vargas et al. · Radiology · 2013 · 125 citations · Full text

Medicine, Radiology, Urology +17

Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results

Nancy E. Kemeny, Lawrence H. Schwartz, Mithat Gönen et al. · Oncology · 2011 · 88 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14